Peripheral T-cell lymphoma

Common Name(s)

Peripheral T-cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripheral T-cell lymphoma" returned 251 free, full-text research articles on human participants. First 3 results:

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients.
 

Author(s): Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Federico Monaco, Debora Degl'Innocenti, Flavia Salvi, Umberto Vitolo, Lisa Argnani, Paolo Corradini, Pier Luigi Zinzani,

Journal:

 

There is no consensus regarding optimal treatment for peripheral T-cell lymphomas (PTCL), especially in relapsed or refractory cases, which have very poor prognosis and a dismal outcome, with 5-year overall survival of 30 %.

Last Updated: 13 Apr 2016

Go To URL
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
 

Author(s): Francine Foss, Steven Horwitz, Barbara Pro, H Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier

Journal:

 

Achievement of durable responses in patients with relapsed/refractory peripheral T cell lymphoma (PTCL) is challenging with current therapies, and there are few data regarding the potential benefits of continuing treatment in patients with the best response of stable disease (SD). ...

Last Updated: 11 Mar 2016

Go To URL
Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
 

Author(s): Scott V Adams, Polly A Newcomb, Andrei R Shustov

Journal: J. Clin. Oncol.. 2016 Mar;34(9):963-71.

 

To compare incidence and survival of peripheral T-cell lymphoma (PTCL) subtypes among US racial/ethnic groups.

Last Updated: 10 Mar 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripheral T-cell lymphoma" returned 26 free, full-text review articles on human participants. First 3 results:

Therapeutic options in peripheral T cell lymphoma.
 

Author(s): Yaping Zhang, Wei Xu, Hong Liu, Jianyong Li

Journal:

 

Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor prognosis. The standard first-line treatments have resulted in unsatisfactory patient outcomes. With the exception of low-risk anaplastic lymphoma kinase (ALK)-positive anaplastic ...

Last Updated: 13 Apr 2016

Go To URL
[Molecular pathogenesis of peripheral T cell lymphoma (2): extranodal NK/T cell lymphoma, nasal type, adult T cell leukemia/lymphoma and enteropathy associated T cell lymphoma].
 

Author(s): Lucile Couronné, Christian Bastard, Philippe Gaulard, Olivier Hermine, Olivier Bernard

Journal: Med Sci (Paris). 2015 Nov;31(11):1023-33.

 

Peripheral T-cell lymphomas (PTCL) belong to the group of non-Hodgkin lymphoma and particularly that of mature T /NK cells lymphoproliferative neoplasms. The 2008 WHO classification describes different PTCL entities with varying prevalence. With the exception of histologic subtype ...

Last Updated: 20 Nov 2015

Go To URL
[Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
 

Author(s): Lucile Couronné, Christian Bastard, Philippe Gaulard, Olivier Hermine, Olivier Bernard

Journal: Med Sci (Paris). 2015 Oct;31(10):841-52.

 

Peripheral T-cell lymphomas (PTCL) belong to the group of non-Hodgkin lymphoma and particularly that of mature T/NK cells lymphoproliferative neoplasms. The 2008 WHO classification describes different PTCL entities with varying prevalence. With the exception of the histological subtype ...

Last Updated: 20 Oct 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphomas

 

Last Updated: 6 Aug 2015

Go to URL
Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
 

Status: Not yet recruiting

Condition Summary: Peripheral T-cell Lymphoma

 

Last Updated: 20 Jun 2016

Go to URL
Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma
 

Status: Recruiting

Condition Summary: Peripheral T Cell Lymphoma

 

Last Updated: 24 Oct 2016

Go to URL